Meitheal Pharmaceuticals, Inc recalls Cetrorelix Acetate for Injection…
Meitheal Pharmaceuticals, Inc recalls Cetrorelix Acetate for Injection (Kit)
- Published
- 18 Feb 2026
- Units affected
- 16,477 kits
- Agency
- FDA
- Country
- United States
The hazard
Defective Delivery System: Missing or duplicated needles within the injection kit
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
- Brand / company
- Meitheal Pharmaceuticals, Inc
- Codes / lots
- Lot Q4E0112A, Exp.: 30 Apr 2027
- Distribution
- U.S. Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 18 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.